• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM513.2
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Intraocular Pressure Increased (1937); Iritis (1940)
Event Date 01/17/2023
Event Type  Injury  
Manufacturer Narrative
Patient information unknown.Adverse event problem: patient related factor.Claim# (b)(4).
 
Event Description
The reporter indicated that a 13.2mm vticm513.2 implantable collamer lens of -11.5/3.0/093 (sphere/cylinder/axis) was implanted into the eye of a patient with pre-existing glaucoma on (b)(6) 2022.Pigment dispersion and iritis were observed.Cause of the event is both a unknown and a patient related factor.Reportedly the status of the eye is, "mostly quiet" and "tapering prednisolone inititated latanoprost in my opinion best irrespective of pigment dispersion, iritis.".
 
Manufacturer Narrative
B5 - "reportedly, 'both icls were removed tuesday (b)(6) 2023 for persistent iop issues from pigment dispersion.Maximal medical therapy had been tried, as well as slt laser for the left.'" should be added to the initial mdr.D6b - explant date: (b)(6) 2023 should be added to the initial mdr.H6 - health effect - impact code: 4627 should be added to the initial mdr.Claim #(b)(4).
 
Manufacturer Narrative
Additional information: b5: the reporter indicated that a 13.2mm vticm513.2 implantable collamer lens of -11.5/3.0/093 (sphere/cylinder/axis) was implanted into the eye of a patient with pre-existing glaucoma on (b)(6) 2022.Pigment dispersion, pressure spikes, and iritis are observed.Reportedly the status of the eye is, "mostly quiet" and "tapering prednisolone initiated latanoprost in my opinion best irrespective of pigment dispersion, iritis." reportedly, 'both icls were removed tuesday (b)(6) 2023 for persistent iop issues from pigment dispersion.Maximal medical therapy had been tried, as well as slt laser for the left.Claim# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SUGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene enriquez
1911 walker avenue
monrovia, CA 91016
8002927902
MDR Report Key16479533
MDR Text Key310628476
Report Number2023826-2023-00722
Device Sequence Number1
Product Code QCB
UDI-Device Identifier00841542116824
UDI-Public00841542116824
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Model NumberVTICM513.2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/02/2023
Initial Date FDA Received03/03/2023
Supplement Dates Manufacturer Received04/13/2023
04/18/2023
Supplement Dates FDA Received04/17/2023
05/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK.
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient SexFemale
-
-